Dr. Andrew Brenner, MD, PhD
Claim this profileUniversity of Texas Health Science Center at San Antonio
Studies Glioblastoma
Studies Recurrence
7 reported clinical trials
10 drugs studied
Area of expertise
1Glioblastoma
IDH negative
Stage IV
MGMT positive
2Recurrence
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Andrew Brenner, MD, PhD is currently running
DSC-MRI
for Recurrent Glioblastoma
This phase II trial studies how well dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) works in measuring relative cerebral blood volume (rCBV) for early response to bevacizumab in patients with glioblastoma that has come back. DSC-MRI may help evaluate changes in the blood vessels within the cancer to determine a patient?s response to treatment.
Recruiting1 award N/A
Rhenium-186 NanoLiposome
for Leptomeningeal Metastasis
This is an open-label Phase I clinical study that will administer a single dose of 186RNL via intraventricular catheter for treatment of Leptomeningeal Metastases (LM).
Recruiting1 award Phase 19 criteria
More about Andrew Brenner, MD, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Andrew Brenner, MD, PhD has experience with
- 186RNL
- Rhenium Liposome Treatment
- Optune®
- VB-111
- Sacituzumab Govitecan
- Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
Breakdown of trials Andrew Brenner, MD, PhD has run
Glioblastoma
Meningeal Carcinomatosis
Leptomeningeal Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Brenner, MD, PhD specialize in?
Andrew Brenner, MD, PhD focuses on Glioblastoma and Recurrence. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are Stage IV.
Is Andrew Brenner, MD, PhD currently recruiting for clinical trials?
Yes, Andrew Brenner, MD, PhD is currently recruiting for 4 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Andrew Brenner, MD, PhD has studied deeply?
Yes, Andrew Brenner, MD, PhD has studied treatments such as 186RNL, Rhenium Liposome Treatment, Optune®.
What is the best way to schedule an appointment with Andrew Brenner, MD, PhD?
Apply for one of the trials that Andrew Brenner, MD, PhD is conducting.
What is the office address of Andrew Brenner, MD, PhD?
The office of Andrew Brenner, MD, PhD is located at: University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 United States. This is the address for their practice at the University of Texas Health Science Center at San Antonio.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.